Related Experiment Video

Updated: Mar 19, 2026

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice
08:40

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Published on: November 22, 2017

18.5K

AMBRA1-induced mitophagy: A new mechanism to cope with cancer?

Flavie Strappazzon1, Francesco Cecconi2

  • 1IRCCS Fondazione Santa Lucia; Rome, Italy; Department of Biology; University of Rome Tor Vergata; Rome, Italy.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Dysfunctional mitophagy, crucial for cancer, involves the protein AMBRA1 binding LC3. This interaction drives mitochondrial clearance, offering new anticancer strategies.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Autophagy Research

Background:

  • Mitophagy, the selective degradation of mitochondria, is vital for cellular health.
  • Dysregulation of mitophagy is increasingly linked to cancer development and progression.
  • Understanding mitophagy pathways is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying mitophagy.
  • To identify novel proteins and pathways involved in mitochondrial clearance.
  • To explore the potential of targeting mitophagy for cancer treatment.

Main Methods:

  • Investigated the interaction between the proautophagic protein AMBRA1 and the autophagosome adapter LC3.
  • Utilized biochemical assays to confirm the binding interaction.
  • Assessed the role of this interaction in mitochondrial clearance in cancer models.

Main Results:

  • Identified a direct binding interaction between AMBRA1 and LC3.
  • Demonstrated that this AMBRA1-LC3 interaction is essential for effective mitochondrial clearance.
  • Showed this pathway functions independently of the E3-ligase PARKIN in certain contexts.

Conclusions:

  • Discovered a novel mitophagy pathway mediated by AMBRA1 and LC3.
  • This pathway is critical for removing damaged mitochondria.
  • The findings open new avenues for anticancer drug development targeting mitophagy.
Keywords:
AMBRA1cancermitophagy

More Related Videos

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

7.6K
Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima09:13

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima

Published on: August 12, 2018

16.0K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.6K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.4K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K